Newsroom

Explore ViewRay events, images & videos, press releases and the most up-to-date coverage of MRIdian.

ViewRay In The News

ViewRay Announces Proposed Public Offering of Common Stock

ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of $125.0million of shares of its common stock. In addition, ViewRay expects to grant the underwriters a 30-day option to purchase up to an additional $18.75million of shares of its common stock at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock to be sold in the offering will be offered by ViewRay. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

August 14, 2018

ViewRay Reports Second Quarter 2018 Financial Results

ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2018. Total revenue for the second quarter ended June 30, 2018 was $16.4 million, compared to $0.7 million for the same period last year.  Revenue for the second quarter ended June 30, 2018 included 3 new MRIdian system installs or delivery, all recognized as product revenue.

August 3, 2018

Leading Medical Physics Meeting to Feature More than 50 Presentations on ViewRay’s MRIdian MRI-Guided Radiotherapy

ViewRay, Inc. (Nasdaq: VRAY), makers of the world’s only FDA-cleared MRI-guided radiation therapy system, announced today that the company’s MRIdian® System is the focus of 55 abstracts selected by the American Association of Physicists in Medicine (AAPM) for presentation during their 2018 Annual Meeting. AAPM is the largest association of medical physicists in the world, and this year’s meeting will be held July 29-August 2 in Nashville.

July 26, 2018

ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors

ViewRay, Inc. (Nasdaq: VRAY), maker of the market-leading MRI-guided radiation therapy system, announced today the appointment of medical device industry veterans Scott Drake as its President and Chief Executive Officer and Shar Matin as its Chief Operating Officer, effective immediately. In connection with his appointment, Mr. Drake has also been appointed to the ViewRay Board of Directors. In addition, ViewRay announced the appointment of D. Keith Grossman to the ViewRay Board of Directors. ViewRay Pre-Releases Preliminary Second Quarter 2018 Revenue of $16 Million and Reaffirms Revenue Guidance of $80 to $90 Million for 2018

July 25, 2018

Webinar: MR Image Guidance and On-Table Adaptive Radiotherapy in Routine Clinical Practice

Oncology professionals: Interested in learning how clinics have integrated MRI-Guided RT into their practice?  Watch the July 26th Webinar and hear from clinicians in Amsterdam and St. Louis, MO who, for several years, have been using real-time image guidance and on-table plan adaptation on the MRIdian® system. Webinar: ow.ly/AdFN30kVafc

July 23, 2018

ViewRay’s MRIdian Linac Awarded French Tender for MR Image-guided Radiation Therapy

ViewRay, Inc. (Nasdaq: VRAY) announced that the company’s MRIdian® Linac has been selected for installation at Centre Georges-François Leclerc (CGFL) in Dijon, France as part of a tender award contract with UNICANCER, a hospital network of 19 French Comprehensive Cancer Centers (FCCCs).

July 11, 2018

Loyola Medicine/Palos Health Installs ViewRay’s MRIdian Linac System for MR Image-Guided Radiation Therapy

ViewRay, Inc. (Nasdaq: VRAY)announced today that Palos Health, in partnership with Loyola Medicine, has installed ViewRay’s MRIdian® Linac System for MR image-guided radiation therapy at its Palos Health South Campus in Orland Park, Illinois. Palos Health becomes the first community hospital in the United States, and the only center in Illinois with the company’s next generation linear accelerator-based system.

July 9, 2018

Nearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided Radiotherapy

The symposium, titled “Advanced Applications of MR-Guided Radiotherapy Symposium,” brought together nearly 200 members of the global oncology community, including radiation oncologists and medical physicists, for talks on various aspects of MR image-guided radiation therapy presented by five experts in the field.

June 21, 2018

University of Wisconsin Begins Patient Treatments with ViewRay’s MRIdian Linac

University of Wisconsin Carbone Cancer Center in Madison, Wisconsin, has begun patient treatments with the company’s MRIdian® Linac, following an upgrade of the hospital’s original MRIdian System. The next-generation MRIdian Linac combines the benefits of MR-image guidance with linear accelerator radiation delivery for the precision treatment of cancer.

June 21, 2018

Pioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System

The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, is treating patients with the company’s second-generation MR image-guided radiotherapy system, the MRIdian® Linac. Siteman is the first U.S. cancer center to offer cancer therapy with both MRIdian and MRIdian Linac, furthering its leadership role in MR image-guided radiation therapy.

June 13, 2018

ViewRay’s Chris Raanes on Bloomberg-Radio

Listen to the Bloomberg-Radio segment

 

June 11, 2018

World-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy Symposium

Experts in MR image-guided radiation therapy will share their experiences during an educational symposium to be held on Friday, September 28, 2018 in Miami. The event aims to facilitate clinical and scientific discovery, as well as educate clinicians interested in the novel advancements of MR image-guided radiation therapy for treating cancer.

May 23, 2018

ViewRay’s Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided Radiotherapy

ViewRay, Inc. (Nasdaq: VRAY) announced today that members of its Clinical Cooperative Think Tank (C2T2) gathered last week in Barcelona, Spain to discuss data from the nearly 3,000 patients treated using ViewRay’s MRIdian MR image-guided radiotherapy system. The group also evaluated new clinical opportunities and potential future trials for this novel technology.

May 2, 2018

ViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital Zurich

ViewRay, Inc. (Nasdaq: VRAY) announced today an order for the company’s MRIdian® MR image-guided linac at the University Hospital Zurich (USZ) in Zurich, Switzerland. The order formalizes the previously announced tender award from the Swiss National R’Equip programme. Once commissioned, the USZ MRIdian system will be the first in Switzerland, and among the first MR-guided linac systems in Europe to treat patients.

March 14, 2018

Simultaneous Tumor Tracking and Treatment Delivers Precise, Accurate Radiation

The Henry Ford Cancer Institute is the first in the world to offer patients an advanced radiation therapy that uses an FDA-approved real-time magnetic resonance imaging (MRI) to deliver more precise and accurate radiation treatment using a linear accelerator. With this new system, called ViewRay MRIdian Linac®, it is now possible to image the treatment area and deliver radiation at the same time -- more effectively protecting surrounding healthy tissue. Watch the Spotlight on Innovation: MRI-Guided Radiation Therapy segment.

November 1, 2017

Cureus Launches Case Report Publishing Competition Aimed at Advancing MR-Guided Radiation Therapy

Competition Seeks to Document MR-Guided Radiotherapy Clinical Applications and Experiences to Increase Information Sharing and Help Improve Cancer Care The Cureus Journal of Medical Science announced today the start of a medical case report publishing competition aimed at advancing the clinical practice of MR-guided radiation therapy by documenting clinical applications and experience and sharing the information freely with the oncology community...All eligible submissions will undergo an independent pre-publication peer review conducted by a world-class team of radiation oncology and medical physics experts; and, three monetary prizes will be awarded to the published articles that receive the highest Cureus SIQ rating. Click the title to view the complete press release from The Cureus Journal of Medicine.

September 28, 2017

ViewRay MRIdian to be Featured in 21 Presentations from Seven Leading Centers at ASTRO

The company's MRIdian and MRIdian Linac systems will be featured at the Annual Meeting of the American Society for Radiation Oncology (ASTRO), with a number of presentations highlighting clinical experience and patient outcomes. The ASTRO meeting will be held September 24-27, 2017 in San Diego. MR-guided radiation therapy remains a significant area of interest, as reflected by the 21 MRIdian clinical presentations and posters accepted as part of ASTRO's Scientific Sessions.

September 21, 2017

MRIdian Linac purchased by Institut du Cancer Montpellier (ICM).

Bringing the benefits of soft-tissue visualization and adaptive therapy to cancer patients throughout France. http://france3-regions.francetvinfo.fr/occitanie/herault/montpellier/radiotherapie-irm-embarquee-cibler-tumeurs-montpellier-fin-2018-1328773.html  

September 16, 2017

Miami Cancer Institute to Acquire ViewRay’s MRIdian Linac for MRI-Guided Radiation Therapy

Miami Cancer Institute, part of Baptist Health South Florida, announced today that it will acquire ViewRay’s MRIdian Linac System, the world’s first and only FDA-cleared MRI-guided radiation therapy system. The MRIdian system will be part of the healthcare organization’s new Miami Cancer Institute, a multidisciplinary, destination cancer center and member of the Memorial Sloan Kettering Cancer Alliance. The MRIdian treatments are expected to be available for patient care in spring 2018.

July 27, 2017

Henry Ford Treats World’s First Patient Using New MRI-Guided Radiation Therapy that Simultaneously Tracks, Treats Tumor

The Henry Ford Cancer Institute has treated the world’s first cancer patient today with an advanced radiation therapy that uses an FDA-cleared real-time magnetic resonance imaging and linear accelerator delivery for more precise and accurate radiation treatment.

July 19, 2017

Orlando Health’s new $30M cancer center to have the latest technology

The new Orlando Health UF Health Cancer Center – Ocoee in Health Central hospital will use Central Florida's latest cancer-tracking technology called MRIdian.

The cutting-edge technology provides a combination of simultaneous radiation therapy and magnetic resonance imaging (MRI) for cancer treatment.

 

June 28, 2017

Moffitt Cancer Center Targets Tumors by Using More Precise Radiation Method

Moffitt Cancer Center recently signed a deal to acquire ViewRay’s MRIdian Linac System, the world’s first and only FDA-cleared MRI-guided radiation therapy system, to assist with precision radiation. MRIdian Linac provides a unique combination of simultaneous radiation therapy delivery and continuous magnetic resonance imaging (MRI) for the treatment of cancer.

June 27, 2017

Two-and-a-half-year clinical experience with the world’s first magnetic resonance image guided radiation therapy system

The first MRI-guided radiation treatment took place in January 2014, at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. The treatment was performed using ViewRay's MRIdian, which integrates a 0.35 T MRI with three gamma-emitting cobalt-60 sources. We report on more than 2 years of clinical experience in treating patients with the world's first MR-IGRT system.

June 1, 2017

ViewRay on Fox News

Watch watch ViewRay on Fox Business “Mornings with Maria” – Aired March 3, 2017 (7 min 58 sec.)

March 3, 2017

ViewRay on CNBC Power Lunch

Watch ViewRay on CNBC-TV’s “Power Lunch” – Aired March 2, 2017 (2 min 17 sec)

March 2, 2017

MRI-Guided Radiation More Precise

Doctors say a medical breakthrough in radiation delivery is ensuring they hit their tumor targets. It also means less toxicity to the surrounding healthy tissue. Here are more details on this high-tech tool that is helping doctors battle cancer at Sylvester Comprehensive Cancer Center in Miami, Florida.

September 26, 2016

MRIdian Making Headlines in Dutch News

VUmc, Amsterdam and MRIdian have been featured on two Dutch news channels: Watch NOS Journaal Video Watch editieNL Video

July 10, 2016

MRIdian Featured on ABC Los Angeles

MRIdian used to treat patient at UCLA - watch Lori’s story and interview with UCLA’s Dr. Percy Lee. Watch the KABC-TV segment

July 1, 2016

SNNLive spoke with Chris A. Raanes, President and CEO of ViewRay, Inc. (OTCQB: VRAY) at the LD Micro “Main Event” 2015 in Bel Air, CA.

In this video interview, Mr. Raanes and our host discuss the following topics: Overview of ViewRay, Inc., Describes the company’s medical device, MRIdian®, Where the technology comes from and currently treating patients, Explains the process for approval process, and where they have been approved, Discusses various indications for the company’s device, Reimbursement, Mr. Raanes’ background, Growth drivers for ViewRay, Inc.

December 15, 2015

Groundbreaking Therapy Opens Window To See Cancerous Tumors In Motion

With the first MRI-guided radiotherapy system in the western U.S.— and one of only three locations in the world — UCLA radiation oncologists have an unparalleled ability to see and accurately target cancerous tumors, while making real-time adjustments to treatment delivery. Beverly Hills Courier, November 2014

November 14, 2014

MRI-Guided Radiation Therapy

Precise adaptive radiation therapy guided by real-time MRI images could prove a significant advance in radiation oncology. Integrating those two tools is the driving force behind the MRIdian system, a combined real-time MRI and radiation therapy delivery process developed by Cleveland-based ViewRay. Radiology Today, September 2014, Vol. 15 No. 9 P. 20

September 1, 2014

Visualizing Tumors During Treatment

A new technology called MRI-guided radiation therapy allows tumors to be visualized in real-time during treatment. In what has been called “a world’s first,” physicians at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis began treating patients with this new therapy in January 2014. Radiation Oncology News for Administrators, June 2014 This article was originally published in Volume 24 No 2 of "Radiation Oncology News for Administrators" © 2014 The Society for Radiation Oncology Administrators (www.sroa.org). The Society for Radiation Oncology Administrators, the authority for radiation oncology operations, provides education, advocacy and information to radiation oncology administrators.

June 1, 2014

ViewRay MRI-Guided Radiation Therapy Used to Treat Cancer Patients

The ViewRay system, a MRI-guided radiation therapy system, is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Mo. The ViewRay system provides a combination of simultaneous radiation therapy delivery and continuous magnetic resonance imaging (MRI) for the treatment of cancer. Imaging Technology News, February 2014

February 10, 2014

Breaking News: World’s only MRI-guided RT System Treats First Patients

The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri has started to treat patients using the ViewRayTM system, the world’s first and only real-time MRI-guided radiation therapy system. The Advisory Board, February 2014

February 7, 2014

ViewRay system gives new insight on MRI-guided therapy for patients

Cancer patients are receiving a significant boost in their treatment options as ViewRay’s (Cleveland) MRI-guided radiation therapy system is being used to treat patients at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine (St. Louis). Medical Device Daily, February 2014

February 1, 2014

Interlinked Motion Control Key to MRI-Guided System

The collimators in the MRI-guided radiotherapy system require multiple components to shape gamma ray radiation therapy beams, and each has to be precisely controlled by one interlinked motion control system. Medical Design, March 2013

March 11, 2013

A New View of Cancer Treatment

ViewRay's president believes the company's MRI machines will revolutionize radiation therapy. "I think this will change the way radiation oncology is practiced,” says Chris Raanes, ViewRay president and CEO. “Because once you've got the ability to see what you are doing in real time, how could you ever go back?” Crain's Cleveland Business, March 2013

March 4, 2013

ViewRay Receives FDA Clearance for MRI-Guided Radiation Therapy System

By using real-time MRI, the ViewRay system shows soft tissue as it is being treated and adjusts for its movement in real time, without using any additional radiation. medGadget, May 2012

May 31, 2012

ViewRay Secures Another $16 Million From Investors

ViewRay is well capitalized for its product launch, says CFO David Chandler, noting that the company has raised $45 million since 2010. Crain's Cleveland Business, March 2012

March 13, 2012

CUSTOMER LOGIN

Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.

Existing Users Log In
   

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy

Accept